BDMD (Baird Medical) חוב כולל להון

This price chart on the GURU.Markets platform demonstrates the individual debt-to-equity ratio for Baird Medical Investment (BDMD), which stands at 0.52. Baird Medical Investment (BDMD) has earned physician recognition by developing safe, high-precision instruments for the cauterization of neoplasms. The brand's innovations enable the destruction of pathologies via thermal radiation, eliminating the need for full tissue incisions. The business currently relies on growing demand in the US and China, which ensures a steady stream of contracts.

This metric measures the proportion of borrowed funds relative to equity, determining the business's degree of financial dependence on external lending. For Baird Medical Investment (BDMD), whose proprietary ablation systems require costly certification and physician training, leverage control is critical to maintaining technological leadership, as clearly reflected in the company's financial leverage chart.